Table 1.
Characteristics of Study Participants Who Had Documentation in the Medical Record
| Characteristics |
Intervention (n=463) |
Usual care (n=459) |
|---|---|---|
| Age, mean (SD), y | 71 (11) | 71 (10) |
| Women, n (%) | 172 (37) | 191 (42) |
| White race, n (%)* | 387 (85) | 380 (84) |
| CHA2DS2‐VASc score, mean (SD) | 3.5 (1.5) | 3.5 (1.5) |
| HAS‐BLED score, mean (SD) | 2.1 (1.1) | 2.1 (1.0) |
| Serum creatinine, N | 331 | 327 |
| Mean (SD) | 1.1 (0.6) | 1.2 (0.8) |
| Cohort, n (%) | ||
| Start (treatment naïve) | 98 (21) | 99 (22) |
| Review | 365 (79) | 360 (78) |
| General health, n (%) † , ‡ | 28 | 31 |
| Excellent/very good | 153 (35) | 138 (32) |
| Good | 188 (43) | 184 (43) |
| Fair/poor | 84 (22) | 106 (25) |
| Total medicines, mean (SD) † , § | 8.1 (4.7) | 7.6 (4.2) |
| Taking aspirin/NSAIDS and/or antiplatelet agents, n (%) † , || | 172 (40) | 151 (36) |
CHA2DS2‐VASc indicates congestive heart failure, hypertension, age ≥75 years, diabetes, stroke or transient ischemic attack, vascular disease, age 65 to 74 years, sex category.
*
Missing (n=16; 7 in intervention arm).
†
Patient reported.
‡
Missing (n=59; 28 in intervention arm).
§
Prescription and over the counter per day, missing (n=65; 32 in intervention arm).
||
Missing (n=69; 31 in intervention arm).